WallStreetZenWallStreetZen

NASDAQ: IKNA
Ikena Oncology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IKNA

Based on 3 analysts offering 12 month price targets for Ikena Oncology Inc.
Min Forecast
$11.00+177.78%
Avg Forecast
$14.00+253.54%
Max Forecast
$18.00+354.55%

Should I buy or sell IKNA stock?

Based on 3 analysts offering ratings for Ikena Oncology Inc.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IKNA stock forecasts and price targets.

IKNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Wedbush
Top 12%
89
BuyInitiates Coverage On$11.00+177.78%2023-09-22
HC Wainwright & Co.
Bottom 4%
4
BuyReiterates$18.00+354.55%2023-08-10
Credit Suisse
Bottom 2%
2
BuyReiterates$13.00+228.28%2023-05-16

1 of 1

Forecast return on equity

Is IKNA forecast to generate an efficient return?
Company
N/A
Industry
0.66%
Market
28.71%

Forecast return on assets

Is IKNA forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%

IKNA revenue growth forecast

How is IKNA forecast to perform vs Biotechnology companies and vs the US market?
Company
1.62%
Industry
34.31%
Market
8.24%
IKNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IKNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IKNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IKNA$3.96$14.00+253.54%Buy
TNYA$2.48$18.00+625.81%Strong Buy
VRCA$4.01$12.00+199.25%Buy
IVA$4.03$19.33+379.73%Strong Buy
ADAP$0.75$5.50+633.33%Hold
View Top Biotech Stocks

Ikena Oncology Stock Forecast FAQ

Is Ikena Oncology Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: IKNA) stock is to Buy IKNA stock.

Out of 3 analysts, 0 (0%) are recommending IKNA as a Strong Buy, 3 (100%) are recommending IKNA as a Buy, 0 (0%) are recommending IKNA as a Hold, 0 (0%) are recommending IKNA as a Sell, and 0 (0%) are recommending IKNA as a Strong Sell.

If you're new to stock investing, here's how to buy Ikena Oncology stock.

What is IKNA's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: IKNA) forecast ROE is N/A, which is considered weak.

What is IKNA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year IKNA price target, the average IKNA price target is $14.00, with the highest IKNA stock price forecast at $18.00 and the lowest IKNA stock price forecast at $11.00.

On average, Wall Street analysts predict that Ikena Oncology's share price could reach $14.00 by Sep 22, 2024. The average Ikena Oncology stock price prediction forecasts a potential upside of 253.54% from the current IKNA share price of $3.96.

What is IKNA's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: IKNA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.05%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.